Cresset Discovery Services contracted by PhoreMost to work on ‘undruggable’ oncology protein target
Cambridge, UK – 4th December 2019 – Cresset Discovery Services, provider of contract research services for early phase discovery, is ...
Welwyn Garden City (20th August 2012) – Cresset BioMolecular Discovery is delighted to announce the appointment of Dr David Bardsley to the newly created role of Sales Director at Cresset Group. David joins Cresset from Synergy Health Plc where, as Sales Director of the Healthcare Solutions division, he was responsible for the organization delivering product solutions to healthcare professionals and institutions.
“This new appointment marks Cresset’s commitment to ensuring companies have the right channels to access software tools and consulting services which are able to streamline their discovery process and tighten their IP position” said Rob Scoffin, Chief Executive Officer of Cresset.
“I am pleased to be joining Cresset BioMolecular Discovery at such an exciting time in their growth strategy. Cresset’s solutions and services have proven successful for many clients and this success can be duplicated to parallel markets and expanded geographies” said David.
David has extensive knowledge in software and technology solutions, with more than twenty years of commercial experience in the scientific market. Prior to Cresset, David was responsible for business development and strategic commercial growth, with both Symyx Technologies and CambridgeSoft. David has a PhD and BSc in Microbiology from the University of Wales Cardiff.